The Enterprise Value as of December 2025 (TTM) for Lipigon Pharmaceuticals AB (publ) (LPGO.ST) is -10658847.00

According to Lipigon Pharmaceuticals AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is -10658847.00. This represents a change of -134.42% compared to the average of 30.97M of the last 4 quarters.

Lipigon Pharmaceuticals AB (publ) (LPGO.ST) Historical Enterprise Value (quarterly & annually)

How has LPGO.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Lipigon Pharmaceuticals AB (publ) over the last ten years is -139266950.42. The current -10658847.00 Enterprise Value has changed 665.35% with respect to the historical average. Over the past ten years (40 quarters), LPGO.ST's Enterprise Value was at its highest in in the March 2020 quarter at 128.50M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Lipigon Pharmaceuticals AB (publ) (LPGO.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lipigon Pharmaceuticals AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lipigon Pharmaceuticals AB (publ) (LPGO.ST) Average Enterprise Value

How has LPGO.ST Enterprise Value performed in the past?

The current Enterprise Value of Lipigon Pharmaceuticals AB (publ) (LPGO.ST) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Lipigon Pharmaceuticals AB (publ) (LPGO.ST) Enterprise Value vs. Peers

How is LPGO.ST’s Enterprise Value compared to its peers?

Lipigon Pharmaceuticals AB (publ)’s Enterprise Value is less than Simris Alg AB (publ) (139.77M), less than AcouSort AB (publ) (33.91M), less than OncoZenge AB (publ) (74.05M), less than Alligator Bioscience AB (publ) (25.98M), less than ExpreS2ion Biotech Holding AB (publ) (6.68M), less than Spago Nanomedical AB (publ) (23.92M), less than Scandinavian Real Heart AB (Publ) (38.61M), less than Sprint Bioscience AB (publ) (144.16M), less than Newbury Pharmaceuticals AB (publ) (22.92M), less than ScandiDos AB (publ) (51.52M),

Build a custom stock screener for Lipigon Pharmaceuticals AB (publ) (LPGO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lipigon Pharmaceuticals AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lipigon Pharmaceuticals AB (publ) (LPGO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lipigon Pharmaceuticals AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.